Frontlight ResearchEarly access
Taking people in United StatesNo phase
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Key facts
- Who runs it
- Edwards Lifesciences
- Where
- Ann Arbor, Atlanta, Chicago, Cleveland, Columbus, Detroit, Kansas City, Los Angeles, Manhasset, Morristown, Naples, Nashville, New York, Palo Alto, Philadelphia, Portland, Rochester, and Seattle, United StatesSee the 21 sites
- Trial code
- Status
- Recruiting
- People taking part
- 85 people, planned
- Started
- 1 Sept 2022
- Expected to end
- 1 Jul 2034
- Type of study
- Interventional
- Treatments tested
- INNOVALVE system
- Record updated
- 21 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Clinically significant, symptomatic mitral regurgitation
- High risk for open-heart surgery
- Meets anatomical criteria
Who cannot take part
- Unsuitable anatomy
- Patient is inoperable
- EF<25%
Where in United States
- University of Michigan Hospital and Health SystemsAnn Arbor, United StatesContact: Keoni FordhamTaking people
- Emory UniversityAtlanta, United StatesContact: Elizabeth CharlesTaking people
- Piedmont Heart InstituteAtlanta, United StatesContact: Jennifer Bolivar AldanaTaking people
- NorthwesternChicago, United StatesContact: BCVI Clinical Trials UnitTaking people
- Cleveland ClinicCleveland, United StatesContact: Emily TylickiTaking people
- OhioHealth Research InstituteColumbus, United StatesContact: Katy MonninTaking people
- Henry Ford HealthDetroit, United StatesContact: Sahar RazmjouTaking people
- Saint Luke's HospitalKansas City, United StatesContact: Brianna VannTaking people
- Cedars SinaiLos Angeles, United StatesContact: Mitch GheorghiuTaking people
- Northwell HealthManhasset, United StatesContact: Samantha AnnunziatoTaking people
- Morristown Medical CenterMorristown, United StatesContact: Catherine Van ZileTaking people
- Naples Comprehensive HealthNaples, United StatesContact: Kathy ByrdTaking people
- Ascension Saint ThomasNashville, United StatesContact: Emily NormandinTaking people
- Vanderbilt University Medical CenterNashville, United StatesContact: Kathy AdamsTaking people
- CornellNew York, United StatesContact: TMTT ClinicalNo longer taking part
- NewYork-Presbyterian / Columbia UniversityNew York, United StatesContact: TMTT ClinicalNo longer taking part
- Stanford UniversityPalo Alto, United StatesContact: Anushka MaratheTaking people
- University of PennsylvaniaPhiladelphia, United StatesContact: Kelli CookTaking people
- Oregon Health & Science UniverstiyPortland, United StatesContact: Emmanuel Mills, MDTaking people
- Mayo ClinicRochester, United StatesContact: Carl GriffinTaking people
- Swedish Medical CenterSeattle, United StatesContact: Zaw Nu DanTaking people
About the trial
What the trial wants to find out
Study to evaluate the safety and performance of the INNOVALVE system
The group in the trial
- TreatmentTreatment being tested
MV replacement with INNOVALVE system
Treatment: INNOVALVE system
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 September 2026